ArticleAddiction (Abingdon, England)2025

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis.

Fares Qeadan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.